Olivier D. Christophe
- Hematology top 0.2%
- Platelet Disorders and Treatments 76
- Hemophilia Treatment and Research 36
- Blood Coagulation and Thrombosis Mechanisms 32
- Blood groups and transfusion 32
- Genetics top 1%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 17
- Immunology top 2%
- Complement system in diseases 26
- Internal Medicine top 5%
- Immunology and Allergy top 5%
-
- Heparin-Induced Thrombocytopenia and Thrombosis 14
-
- Monoclonal and Polyclonal Antibodies Research 13
- Co-authors
- Peter J. LentingCécile V. DenisCaterina CasariFrançois M. ValletteLisenn LalierLisa OliverPaulette LegendreOleg Melnyk
- Cited by
- HematologyGeneticsImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (8 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
Olivier D. Christophe
139 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 131
- Hematology 2.3k
- Genetics 612
- Immunology 927
- Internal Medicine 115
- Immunology and Allergy 138
Countries citing papers authored by Olivier D. Christophe
This map shows the geographic impact of Olivier D. Christophe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier D. Christophe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier D. Christophe more than expected).
Fields of papers citing papers by Olivier D. Christophe
This network shows the impact of papers produced by Olivier D. Christophe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier D. Christophe. The network helps show where Olivier D. Christophe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olivier D. Christophe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 19 | |
| 8 | KB-V13A12, a novel nanobody-based therapeutic molecule for the treatment of von Willebrand disease | 2023 | 2 |
| 9 | 2023 | 4 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 23 | |
| 15 | 2021 | 14 | |
| 16 | 2021 | 25 | |
| 17 | 2020 | 10 | |
| 18 | 2020 | 44 | |
| 19 | 2020 | 19 | |
| 20 | 2015 | 292 |
About Olivier D. Christophe
Olivier D. Christophe is a scholar working on Hematology, Genetics and Immunology, having authored 144 papers that have together received 4.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (76 papers), Hemophilia Treatment and Research (36 papers), Blood Coagulation and Thrombosis Mechanisms (32 papers), Blood groups and transfusion (32 papers), Complement system in diseases (26 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Heparin-Induced Thrombocytopenia and Thrombosis (14 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (612 citations) and Immunology (927 citations). Olivier D. Christophe has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include Peter J. Lenting, Cécile V. Denis, Caterina Casari, François M. Vallette, Lisenn Lalier, Lisa Oliver, Paulette Legendre, Oleg Melnyk, Philip G. de Groot and Julie Pegon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.